OSU-13

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameOSU-13
Drug Alias NameOSU-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity protein kinase TTK inhibitors
TargetsDual specificity protein kinase TTK
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State University
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A